Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors.

Tal SellaPhilip D PoorvuKathryn J RuddyShari I GelberRulla M TamimiJeffrey M PeppercornLidia SchapiraVirginia F BorgesSteven E ComeAnn H Partridge Shoshana M Rosenberg

Published in: Cancer (2021)

Concern about fertility is a contributor to adjuvant ET decisions among a substantial proportion of young breast cancer survivors. Ensuring family planning is addressed in the setting of ET recommendations should be a priority throughout the cancer care continuum.

Keyphrases

early stage
childhood cancer
clinical practice
stem cells
mesenchymal stem cells
young adults
cell therapy